Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene

Annals of Surgery

Volumn 230, Issue 2, 1999, Pages 185-193

  Bilbao, Guadalupe ^a   Contreras, Juan L ^a   Eckhoff, Devin E ^a   Mikheeva, Galina ^a   Krasnykh, Victor ^a   Douglas, Joanne T ^a   Thomas, Francis T ^a   Thomas, Judith M ^a   Curiel, David T ^a,b  

^a Kentucky   (United States)

^b Gene Therapy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; GENE TRANSFER; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, BCL-2; LIVER; MALE; MICE; MICE, INBRED C57BL; REPERFUSION INJURY; SURVIVAL RATE; TIME FACTORS;

EID: 0033505577     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199908000-00008     Document Type: Article

References (62)

1. Kohli V, Gao W, Camargo CAJ, Clavien PA. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad Sci USA 1997; 94:9354-9359.
2. Lie TS, Seger R, Hong GS, Preissinger H, Ogawa K. Protective effect of aprotinin on ischemic hepatocellular damage. Transplantation 1989; 48:396-399.
3. Gasbarrini AP, Pasini P, Nardo B, et al. Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. Free Radic Biol Med 1998; 24:211-216.
4. Hochachka PW. Defense strategies against hypoxia and hypothermia. Science 1986; 231:234-241.
5. Thomas CE, Reed DJ. Current status of calcium in hepatocellular injury. Hepatology 1989; 10:375-384.
6. Gores GJ, Flarsheim CE, Dawson TL, et al. Swelling, reductive stress, and cell death during chemical hypoxia in hepatocytes. Am J Physiol 1989; 257:C347-C354.
7. Marubayashi S, Oshiro Y, Maeda T, et al. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Surgery 1997; 122:45-52.
8. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna CP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985; 40:584-590.
9. Le MO, Louis H, Stordeur P, et al. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology 1997; 113:1701-1706.
10. Negita M, Hayashi S, Koike S, et al. Protective effect of human superoxide dismutase cDNA transfection in the prevention of cold preservation injury. Transplant Proc 1997; 29:1363.
11. Simpson KJ, Lukacs NW, Colletti L, Strieter RM, Kunkel SL. Cytokines and the liver. J Hepatol 1997; 27:1120-1132.
12. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998; 27:507-512.
13. Horie Y, Wolf R, Russell J, Shanley TP, Granger DN. Role of Kupffer cells in gut ischemia/reperfusion-induced hepatic microvascular dysfunction in mice. Hepatology 1997; 26:1499-1505.
14. Yamaguchi Y, Matsumura F, Takeya M, et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology 1998; 27:727-734.
15. Zwacku RM, Zhang Y, Halldorson J, et al. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100:279-289.
16. Borghi-Scoazec G, Scoazec JY, Durand F, et al. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transpl Surg 1997; 3:407-415.
17. Galle PR. Apoptosis in liver disease. J Hepatol 1997; 27:405-412.
18. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: An overview. Semin Liver Dis 1998; 18:105-114.
19. Patel T, Gores JG. Apoptosis in liver transplantation: A mechanism contributing to immune modulation, preservation injury, neoplasia, and viral disease. Liver Transpl Surg 1998; 4:42-50.
20. Sasaki H, Matsuno T, Tanaka N, Orita K. Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc 1996; 28:1908-1909.
21. Sasaki H, Matsuno T, Ishikawa T, et al. Activation of apoptosis during early phase of reperfusion after liver transplantation. Transplant Proc 1997; 29:406-407.
22. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis [published erratum appears in Nat Med 1997 Aug;3(8):934]. Nat Med 1997; 3:614-620.
23. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10:1-15.
24. Shimizu S, Eguchi Y, Kosaka H, et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995; 374:811-813.
25. Shimizu S, Eguchi Y, Kamiike W, et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res 1996; 56:2161-2166.
26. Yamabe K, Shimizu S, Kamiike W, et al. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem Biophys Res Commun 1998; 243:217-223.
27. Zhong LT, Sarafian T, Kane DJ, et al. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993; 90:4533-4537.
28. Lawrence MS, Ho DY, Sun GH, et al. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 1996; 16:486-496.
29. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992; 258:302-304.
30. Liu Y, Rabinovitch A, Suarez-Pinzon W, et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic b-cells from apoptosis. Hum Gene Ther 1996; 7:1719-1726.
31. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13:1017-1030.
32. Shimazaki K, Ishida A, Kawai N. Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci Res 1994; 20:95-99.
33. Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997; 150:1985-1995.
34. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol 1997; 272: G1587-G1593.
35. Gapany C, Zhao M, Zimmermann A. The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts. J Hepatol 1997; 26:535-542.
36. Krams SM, Egawa H, Quinn MB, et al. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59:621-625.
37. Yamamoto H, Ohdan H, Shintaku S, et al. Analysis of apoptosis-associated genes: Fas ligand, bcl-2 and bax in the rat liver allograft. Transplant Proc 1998; 30:22-24.
38. Hitt MM, Addison CL, Graham FL. Human adenovirus vectors for gene transfer into mammalian cells. In: August JT, ed. Gene therapy. London: Academic Press; 1996:138-206.
39. Camargo CAJ, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26:1513-1520.
40. Horie Y, Wolf R, Anderson DC, Granger DN. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. J Clin Invest 1997; 99:781-788.
41. Bilbao G, Contreras JL, Gomez-Navarro J. et al. Genetic modification of liver grafts with an adenoviral vector encoding the bcl-2 gene improves organ preservation. Transplantation 1999; 67:775-783.
42. Vrancken Peeters MJ, Lieber A, Perkins J, Kay MA. Method of multiple portal vein infusions in mice: Quantification of adenovirus-mediated hepatic gene transfer. BioTechniques 1996; 20:278-285.
43. Vrancken Peeters, MJ, Patjin GA, Lieber A, Meuse L, Kay MA. Adenovirus-mediated hepatic gene transfer in mice: Comparison of intravascular and biliary administration. Hum Gene Ther 1996; 7:1693-1698.
44. Iu S, Harvey PR, Makowka L, et al. Markers of allograft viability in the rat. Relationship between transplantation viability and liver function in the isolated perfused liver [published erratum appears in Transplantation 1987 Dec;44(6):835]. Transplantation 1987; 44:562-569.
45. Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996; 70: 8934-8943.
46. Jooss K, Yang Y, Wilson JM. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum Gene Ther 1996; 7:1555-1566.
47. Okabe H, Kurosawa K, Hatanaka N, et al. Protection of cellular and mitochondrial functions against anoxic damage by fructose in perfused liver. Biochim Biophys Acta 1991; 1098:41-48.
48. Todo S, Zhu Y, Zhang S, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997; 63: 217-223.
49. 2+ release from mitochondria induces cytosolic enzyme leakage in anoxic liver. J Surg Res 1995; 58:485-490.
50. Pastonno JG, Snyder JW, Serroni A, et al. Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem 1993; 268:13791-13798.
51. Watanabe F, Kamiike W, Nishimura T, et al. Decrease in mitochondrial levels of adenine nucleotides and concomitant mitochondrial dysfunction in ischemic rat liver. J Biochem 1983; 94:493-499.
52. Shimizu S, Eguchi Y, Kamiike W, et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 1996; 13:21-29.
53. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182:367-377.
54. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392:86-89.
55. Rovere P, Vallinoto C, Bondanza A, et al. Cutting edge: Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161:4467-4472.
56. Chiu VK, Walsh CM, Liu CC, et al. Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity. J Immunol 1995; 209:211-218.
57. Delva E, Camus Y, Nordlinger B, et al. Vascular occlusions for liver resections: Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989; 209:211-218.
58. Huguet C, Gavelli P, Chieco A, et al. Liver ischemia for hepatic resection: Where is the limit? Surgery 1992; 111:251-259.
59. Okuyama T, Li X-K, Funeshima N, et al. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors. J Gatroenterol Hepatol 1998; 13(Suppl):S113-118.
60. Lacronique V, Mignon A, Fabre M, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996; 2:80-86.
61. Tsujimoto Y, Gorham J, Cossman J, et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229:1390-1393.
62. Katsumata M, Siegel RM, Louie DC, et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 1992; 89:11376-11380.